After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, ZVRA falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Zevra Therapeutics Inc is $470.80M. A total of 0.77 million shares were traded on the day, compared to an average of 522.42K shares.
In the most recent transaction, Watton Corey Michael bought 300 shares of ZVRA for 7.84 per share on Mar 28 ’25. After the transaction, the Director now owns 1,800 company shares. In a previous transaction on Mar 19 ’25, Bode John B bought 10,000 shares at 7.96 per share. ZVRA shares that Director owns now total 40,000.
Among the insiders who sold shares, Sangiovanni Timothy J. disposed of 3,000 shares on Feb 13 ’25 at a per-share price of $7.86. This resulted in the SVP, Finance & Corp Controller holding 16,341 shares of ZVRA after the transaction. In another insider transaction, Schafer Joshua sold 10,500 shares at $7.86 per share on Feb 13 ’25. Company shares held by the CCO & EVP, Bus. Development now total 29,486.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, ZVRA has a high of $9.76 and a low of $4.20.
As of this writing, ZVRA has an earnings estimate of $1.11 per share for the current quarter. EPS was calculated based on a consensus of 8.0 estimates, with a high estimate of $2.64 per share and a lower estimate of -$0.12.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. ZVRA’s latest balance sheet shows that the firm has $112.35M in Cash & Short Term Investments as of fiscal 2021. There were $1.61M in debt and $4.23M in liabilities at the time. Its Book Value Per Share was $0.75, while its Total Shareholder’s Equity was $127.12M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
